Main
>
ENDOCRINOLOGY
>
Diabetes. Treatment
>
VildaGliptin (DPP-IV Inhibitor)
>
Co.: CH. N. (EU Approved/Patents)
>
Patent>US Expiration: 12.09.2019
Patent>US Expiration: 12.09.2019's products
This section has no products